About CH Tourcoing
"Le Centre Hospitalier de Tourcoing est un établissement public de santé. Il est membre du Groupement Hospitalier Territorial Lille Métropole Flandre Intérieure. L'hôpital comptabilise près de 155 000 consultations et possède 971 lits, dont 463 lits dédiés à la Médecine, Chirurgie et Obstétrique, localisés au niveau de l'hôpital Guy Chatiliez. Prenez contact."
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
University Hospital, Lille
15
Tourcoing Hospital
11
ANRS, Emerging Infectious Diseases
9
Gilead Sciences
8
Bristol-Myers Squibb
3
Centre Hospitalier Universitaire, Amiens
3
Institut de Médecine et d'Epidémiologie Appliquée - Fondation Internationale Léon M'Ba
3
Intergroupe Francophone de Cancerologie Thoracique
3
Centre Oscar Lambret
2
DatAids
2
Federation Francophone de Cancerologie Digestive
2
Clinical Trials at CH Tourcoing
During the past decade, CH Tourcoing conducted 52 clinical trials. In the 10-year time frame, 52 clinical trials started and 9 clinical trials were completed, i.e. on
average, 17.3% percent of trials that started reached the finish line to date. In the past 5 years, 28 clinical trials started and 2 clinical trials were completed. i.e. 7.1%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study to Compare Two Anti-HIV Drug Combinations in HIV-Infected Patients Who Have Previously Received Anti-HIV Treatment
Completed
300
Safety and Effectiveness of a New Protease Inhibitor, BMS-232632, in HIV-Positive Patients Who Have Received Previous Treatment
1999-12-01
2002-01-01
Completed
A Comparison of BMS-232632 With Efavirenz, Each in Combination With Zidovudine-Lamivudine
2001-02-01
2003-04-01
Completed
Atazanavir Versus Lopinavir/Ritonavir (LPV/RTV) in Patients Who Have Not Had Success With Protease Inhibitor-Containing HAART Regimen(s)
2001-02-01
2003-09-01
Completed
Prospective Observational Epidemiologic Study of Maraviroc's Safety
2008-03-31
2019-02-14
Completed
2,500
Follow-Up Care With or Without CEA Assessments in Patients Who Have Undergone Surgery for Stage II or Stage III Colorectal Cancer
2009-09-01
2021-06-01
Completed
1,997
Optimisation of Primary HIV1 Infection Treatment(ANRS 147 OPTIPRIM)
2010-04-01
2013-12-01
Completed
90
Study of Darunavir/r + Tenofovir/Emtricitabine vs. Darunavir/r + Raltegravir in HIV-infected Antiretroviral naïve Subjects
2010-08-01
2013-10-01
Completed
800
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "CH Tourcoing" #1 sponsor was "University Hospital, Lille" with 15 trials, followed by "Tourcoing Hospital" with 11 trials
sponsored, "ANRS, Emerging Infectious Diseases" with 9 trials sponsored, "Gilead Sciences" with 8 trials sponsored and "Bristol-Myers Squibb"
with 8 trials sponsored. Other sponsors include 33 different institutions and
companies that sponsored additional 30 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "CH Tourcoing"
#1 collaborator was "Ministry of Health, France" with 6 trials as a collaborator, "Pfizer" with 4 trials as a collaborator, "Région Nord-Pas de Calais, France" with 3 trials as a collaborator, "ViiV Healthcare" with 2 trials as a collaborator and "ARCAGY/ GINECO GROUP" with 1 trials as a collaborator. Other collaborators include 28 different institutions and companies that were
collaborators in the rest 38 trials.
Clinical Trials Conditions at CH Tourcoing
According to Clinical.Site data, the most researched conditions in "CH Tourcoing" are
"HIV Infections" (13 trials), "HIV" (7 trials), "HIV-1 Infection" (6 trials), "Covid19" (5 trials) and "COVID-19" (4 trials). Many other conditions were trialed in "CH Tourcoing" in a lesser frequency.
Clinical Trials Intervention Types at CH Tourcoing
Most popular intervention types in "CH Tourcoing" are "Drug" (41 trials), "Other" (25 trials), "Behavioral" (3 trials), "Biological" (2 trials) and "Device" (2 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (9 trials), "FTC/TDF" (4 trials), "ATV" (3 trials), "Atazanavir" (3 trials) and "Questionnaire" (3 trials). Other intervention names were less common.
Clinical Trials Genders at CH Tourcoing
The vast majority of trials in "CH Tourcoing" are
80 trials for "All" genders, 3 trials for "Male" genders and 1 trials for "Female" genders.
Clinical Trials Status at CH Tourcoing
Currently, there are NaN active trials in "CH Tourcoing".
4 are not yet recruiting,
18 are recruiting,
4 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 45 completed trials in CH Tourcoing,
undefined suspended trials,
and 6 terminated clinical trials to date.
Out of the total trials that were conducted in CH Tourcoing, 1 "Phase 1"
clinical trials were conducted, 11 "Phase 2" clinical
trials and 31 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 3 trials, and there were
also 17 trials that are defined as “Not Applicable".